Observational studyPloS one2017

Treatment satisfaction with injectable disease-modifying therapies in patients with relapsing-remitting multiple sclerosis (the STICK study).

Oscar Fernández et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.